Head-to-head · WeighScore
LaSara Medical Group vs MEDVidi
The verdict
MEDVidi takes it — 58/100 to 54.5/100.
MEDVidi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MEDVidi is a US telehealth platform whose licensed providers evaluate patients and prescribe GLP-1 weight-management medications, including brand-name Zepbound (tirzepatide) and Wegovy (semaglutide), plus…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | LaSara Medical Group | MEDVidi |
|---|---|---|
| WeighScore | 54.5/100 | 58/100 |
| Grade | C | C |
| Scorecard rank | #455 | #384 |
| Semaglutide | $289/mo (compounded) | Not disclosed |
| Tirzepatide | $399/mo (bundle, compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #455 · C
Strengths
- Multi-modality clinic — compounded GLP-1s alongside TRT, peptides, B12, NAD+, sermorelin, and enclomiphene
- National telehealth plus an in-person option in Southern California — uncommon hybrid model
- Free initial consultation
- Active promotional pricing (30% off sitewide at the time of review)
- GLP-1 pricing now published on product pages: compounded semaglutide from $233/mo, tirzepatide from $325/mo on annual bundles
Where it loses points
- Legal entity name and state of incorporation not disclosed
- Compounding pharmacy partner not named
- LegitScript certification status not confirmed
- Per-state availability not listed despite the national-telehealth claim
- Lab work and ongoing monitoring inclusion not clearly disclosed for the multi-modality menu
Graded #384 · C
Strengths
- Licensed providers can prescribe brand-name Zepbound and Wegovy
- Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
- Prescriptions sent to the patient's pharmacy of choice, so insurance can be used
Where it loses points
- Consult-fee model: medication is not included and its cost is separate
- No medication pricing is published
- State list is shown as a map rather than enumerated
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.